Pluribus Labs’s Agilent Technologies A Stock Holding History

Pluribus Labs’s Portfolio A Stock Details A Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,087	Closed	-$652K	–	45
2021 Q4	$652K	Buy	+4,087	New	+$637K	0.69%	24

Other funds holding A

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Pluribus Labs's A Position: Q1 2022 in Review

Pluribus Labs sold out of Agilent Technologies (A) in Q1 2022, closing a stake of 4,087 shares — an estimated $652K sold.

Pluribus Labs first reported a position in A in Q4 2021 and held it in 1 quarter. The position peaked at $652K in Q4 2021. 931 funds tracked by Wall St. Rank hold A as of Q1 2022.

Pluribus Labs reported no remaining Agilent Technologies position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 4,087 Agilent Technologies shares in Q1 2022, an estimated $652K.
Pluribus Labs first reported a position in Agilent Technologies in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Agilent Technologies position peaked at $652K in Q4 2021.
931 funds tracked by Wall St. Rank held Agilent Technologies as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.